Talid Tablet (Talniflumeate)
Talniflumate 370mg
Tablet · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.
MFDS item code 200402716 · Notified 2004.05.18
This product's status changed to Expired on 2024.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of arthritis (including rheumatoid arthritis)
This medication is used for rheumatoid arthritis and osteoarthritis (degenerative joint disease).
Administer talniflumate 370 mg orally 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.
This medication should be discussed with a doctor or pharmacist before taking if you regularly consume more than three alcoholic drinks per day. This medication may increase the risk of cardiovascular diseases, so patients with heart conditions or risk factors should use it with caution. This medication can cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforations, especially in elderly patients or those with a history of gastrointestinal diseases. Patients with peptic ulcers or hypersensitivity to this medication, those with severe liver, kidney, or heart diseases, pregnant women, and breastfeeding women should not take this medication. Patients with mild to moderate liver or kidney function impairment, elderly patients, and those taking diuretics should be closely monitored while using this medication. This medication may cause hypersensitivity reactions such as nausea, vomiting, skin rashes, and asthma attacks; if any unusual symptoms occur, you should consult a healthcare professional immediately. Regular monitoring of liver function, kidney function, and blood tests should be conducted during long-term use to check for abnormalities, and administration should be stopped if symptoms worsen. This medication may interact with other anti-inflammatory analgesics, antihypertensives, anticoagulants, diuretics, and if you are taking any other medications, you should inform your healthcare provider. Women who are pregnant or may become pregnant should not take this medication, and breastfeeding women are advised to discontinue breastfeeding or the medication.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure and kept at a temperature between 1 and 30 degrees Celsius. Storing it this way can help maintain its effectiveness.
Yellow round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Talniflumate 370mg
Tablet · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

Talniflumate 370mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.

Talniflumate 370mg
Tablet · Prescription medication
Dongsung Pharm Co., Ltd.

Talniflumate 370mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.
Talniflumate 370mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Talniflumate 370mg
Tablet · Prescription medication
Taegeuk Pharmaceutical Co., Ltd.

Talniflumate 370mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Talniflumate 370mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.